4
MARKET OVERVIEW
Rising smartphone use and AI integration revolutionize patient-centric mHealth amidst regulatory challenges.
46
4.2.1.1
INCREASING PENETRATION OF SMARTPHONES, TABLETS, AND OTHER MOBILE PLATFORMS
4.2.1.2
RISING FOCUS ON PATIENT-CENTRIC HEALTHCARE DELIVERY
4.2.1.3
RAPID ADOPTION OF WEARABLES EXPANDS CONNECTED MHEALTH ECOSYSTEMS
4.2.1.4
CHRONIC DISEASE BURDEN DRIVES DEMAND FOR REMOTE MONITORING AND CONNECTED DEVICES
4.2.2.1
COMPLEXITY OF REGULATORY LANDSCAPE
4.2.2.2
FRAGMENTATION OF MHEALTH ECOSYSTEM
4.2.2.3
INTEROPERABILITY CONSTRAINTS
4.2.3.1
AI AND PREDICTIVE ANALYTICS EXPAND MHEALTH CAPABILITIES
4.2.3.2
GROWING ADOPTION ACROSS EMERGING MARKETS
4.2.3.3
STRATEGIC PARTNERSHIPS AND COLLABORATIONS AMONG HEALTHCARE COMPANIES AND MHEALTH PROVIDERS
4.2.3.4
TELEHEALTH GROWTH EXPANDS MOBILE CARE DELIVERY
4.2.4.1
REIMBURSEMENT BARRIERS RESTRICT WIDER MHEALTH ADOPTION
4.2.4.2
CONCERNS ASSOCIATED WITH DATA SECURITY
4.2.4.3
RAPID TECHNOLOGY EVOLUTION INCREASES MHEALTH DEVELOPMENT COMPLEXITY
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive healthcare IT landscapes with strategic insights from industry forces and pricing dynamics.
57
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025)
5.5.2
INDICATIVE PRICE FOR MHEALTH SOLUTIONS MARKET, BY REGION (2025)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1
CASE 1: CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA)
5.9.2
CASE STUDY 2: NOVA HOSPITAL & ENOVACOM
5.9.3
CASE STUDY 3: APPLE & NHS TEAMS
5.10
IMPACT OF 2025 US TARIFF – OVERVIEW
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRY/REGION
5.10.5
IMPACT ON END USERS
5.10.5.1
HEALTHCARE PROVIDERS
5.10.5.2
HEALTHCARE PAYERS
5.10.5.3
PATIENTS AND CONSUMERS
5.10.5.4
OTHER END USERS (ACADEMIC INSTITUTES, RESEARCH CENTERS, GOVERNMENT BODIES, ETC.)
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
AI AND MACHINE LEARNING
6.1.4
COMPLEMENTARY TECHNOLOGIES
6.1.5
CONNECTED MEDICAL DEVICES
6.1.7
TELEMEDICINE PLATFORMS
6.1.8
ADJACENT TECHNOLOGIES
6.1.8.1
PRECISION MEDICINE
6.1.8.2
CLINICAL DECISION SUPPORT SYSTEMS
6.1.8.3
HEALTHCARE DATA ANALYTICS
6.2.1
PATENT PUBLICATION TRENDS FOR THE MHEALTH SOLUTIONS
6.2.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.3.1
AI-POWERED PREDICTIVE HEALTH MONITORING
6.3.2
PERSONALIZED DIGITAL HEALTH COACHING
6.3.3
CONTINUOUS REMOTE PATIENT MONITORING
6.3.4
AI-ENABLED EARLY DISEASE DETECTION
6.3.5
MOBILE MEDICATION ADHERENCE AND MANAGEMENT
6.4
IMPACT OF AI/GEN AI ON MHEALTH SOLUTIONS MARKET
6.4.2
MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS MARKET
6.4.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.4.3.1
COTTAGE HEALTH EXPANDS AI-ASSISTED VIRTUAL CARE AND PATIENT SAFETY PLATFORM ENTERPRISE-WIDE
6.4.3.2
APOLLO HOSPITALS DEPLOYS AI-ENABLED CONNECTED CARE ACROSS HEALTHCARE CONTINUUM
6.4.4
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
6.4.4.1
AI-POWERED SYMPTOM ASSESSMENT & TRIAGE
6.4.4.2
PREDICTIVE HEALTH ANALYTICS
6.4.4.3
CONVERSATIONAL HEALTH ASSISTANTS
6.4.4.4
MEDICATION & TREATMENT SUPPORT
6.4.5
USER READINESS AND IMPACT ASSESSMENT
6.4.5.1.1
HEALTHCARE PROVIDERS
6.4.5.1.2
HEALTHCARE PAYERS
6.4.5.1.3
PATIENTS/CONSUMERS
6.4.5.2
IMPACT ASSESSMENT
6.4.5.2.1
USER A: HEALTHCARE PROVIDERS
6.4.5.2.2
USER B: HEALTHCARE PAYERS
6.4.5.2.3
USER B: PATIENTS/CONSUMERS
6.4.6
REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
6.4.7
REGULATORY ANALYSIS
7
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Understand buyer dynamics and unmet needs to unlock mHealth market profitability.
96
7.2
DECISION-MAKING PROCESS
7.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
7.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
7.5
UNMET NEEDS FROM VARIOUS END USERS
7.5.2
END USER EXPECTATIONS
8
MHEALTH SOLUTIONS MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 27 Data Tables
102
8.2.1
GROWING ADOPTION FOR PERSONALIZED AND CONNECTED HEALTHCARE TO DRIVE SEGMENT
8.2.2
CHRONIC CARE MANAGEMENT APPS
8.2.2.1
INCREASING NEED FOR CONTINUOUS, PERSONALIZED CHRONIC CARE MANAGEMENT TO BOOST DEMAND
8.2.3
MENTAL & BEHAVIORAL HEALTH APPS
8.2.3.1
GROWING DEMAND FOR ACCESSIBLE AND CONVENIENT MENTAL HEALTHCARE TO DRIVE SEGMENT
8.2.4
GENERAL HEALTH & FITNESS APPS
8.2.4.1
FOCUS ON PERSONALIZED HEALTH, FITNESS, AND WELLNESS MANAGEMENT TO PROPEL SEGMENT
8.2.5
MEDICATION MANAGEMENT & ADHERENCE APPS
8.2.5.1
SEGMENT DRIVEN BY NEED FOR IMPROVED MEDICATION ADHERENCE AND TREATMENT MANAGEMENT
8.2.6
WOMEN’S HEALTH APPS
8.2.6.1
RAPID ADOPTION OF MOBILE TECHNOLOGIES FOR PERSONALIZED WOMEN’S HEALTH MANAGEMENT
8.2.7
DIAGNOSTIC & SYMPTOM CHECKER APPS
8.2.7.1
INCREASING NEED FOR CONVENIENT DIGITAL HEALTH ASSESSMENT AND DIAGNOSTIC SUPPORT TO DRIVE SEGMENT
8.2.8
PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS
8.2.8.1
GROWING NEED FOR ACCESSIBLE AND CONNECTED PATIENT HEALTH INFORMATION TO BOOST MARKET
8.2.9
CLINICAL DECISION SUPPORT APPS
8.2.9.1
RAPID ADOPTION OF MEDICAL APPLICATIONS FOR CLINICAL MONITORING AND DECISION SUPPORT TO DRIVE SEGMENT
8.2.10
OTHER HEALTHCARE APPS
8.2.10.1
HIGH DEMAND FOR DIGITAL HEALTHCARE INFORMATION AND PATIENT ENGAGEMENT TO GROW MARKET
8.3
CONNECTED MEDICAL DEVICES
8.3.1
ADVANCING CONNECTED TECHNOLOGIES FOR CONTINUOUS AND PERSONALIZED HEALTH MONITORING TO DRIVE MARKET
8.3.2
VITAL SIGNS MONITORING DEVICES
8.3.2.1
EXPANDING ROLE OF CONNECTED MONITORING IN CONTINUOUS PATIENT ASSESSMENT TO BOOST SEGMENT
8.3.3
SLEEP MONITORING DEVICES
8.3.3.1
ADVANCING CONNECTED TECHNOLOGIES FOR SLEEP HEALTH MANAGEMENT
8.3.4
MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES
8.3.4.1
INCREASING INTEGRATION OF MULTIPARAMETER MONITORING ACROSS CARE SETTINGS TO BOOST MARKET
8.3.5
FETAL & MATERNAL MONITORING DEVICES
8.3.5.1
ENHANCED MATERNAL AND FETAL CARE THROUGH WIRELESS MONITORING TO DRIVE SEGMENT
8.3.6
NEUROLOGICAL MONITORING DEVICES
8.3.6.1
SEGMENT DRIVEN BY ADVANCES IN CONNECTED TECHNOLOGIES FOR NEUROLOGICAL MONITORING
8.3.7
SMART INHALERS & DRUG DELIVERY DEVICES
8.3.7.1
IMPROVED MEDICATION MANAGEMENT THROUGH CONNECTED DRUG DELIVERY TO BOOST MARKET
8.3.8
OTHER CONNECTED MEDICAL DEVICES
8.3.8.1
BROADENING APPLICATIONS OF CONNECTED DEVICES IN SPECIALIZED HEALTHCARE
8.4.1
EXPANDING ACCESS TO CONNECTED AND PATIENT-CENTRIC HEALTHCARE SERVICES TO BOOST MARKET
8.4.2
REMOTE PATIENT MONITORING SERVICES
EXTENDING CLINICAL OVERSIGHT BEYOND TRADITIONAL CARE SETTINGS –
8.4.3
TELEHEALTH SERVICES
8.4.3.1
BROAD ACCESS TO VIRTUAL AND ON-DEMAND HEALTHCARE TO BOOST DEMAND
8.4.4
DIGITAL DISEASE MANAGEMENT SERVICES
8.4.4.1
SHIFTING CHRONIC DISEASE MANAGEMENT TOWARD CONTINUOUS DIGITAL CARE
8.4.5.1
CONNECTED CARE STRENGTHENED THROUGH IMPLEMENTATION, SUPPORT, AND DIGITAL REHABILITATION
9
MHEALTH SOLUTIONS MARKET, BY USE CASE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 9 Data Tables
127
9.2
PREVENTIVE CARE & WELLNESS
9.2.1
AI AND WEARABLES DRIVE PREVENTIVE MHEALTH ADOPTION
9.3
SCREENING & DIAGNOSIS
9.3.1
MOBILE AND AI-ENABLED TOOLS EXPANDING ACCESS TO EARLY SCREENING & DIAGNOSIS
9.4
TREATMENT & DISEASE MANAGEMENT
9.4.1
CONNECTED DEVICES AND DIGITAL THERAPEUTICS STRENGTHENING MHEALTH-BASED DISEASE MANAGEMENT
9.5.1
WEARABLES AND REMOTE MONITORING ENABLE CONTINUOUS PATIENT OVERSIGHT
9.6
MEDICATION MANAGEMENT & ADHERENCE
9.6.1
MOBILE PLATFORMS AND DIGITAL TOOLS IMPROVING MEDICATION ADHERENCE
9.7
CONSULTING & CARE COORDINATION
9.7.1
DIGITAL CONNECTIVITY ENABLES ENHANCED COORDINATED CARE DELIVERY
9.8
REHABILITATION & RECOVERY
9.8.1
DIGITAL REHABILITATION EXTENDS RECOVERY BEYOND TRADITIONAL THERAPY SETTINGS
9.9.1
MOBILE HEALTH EXPANDS POPULATION-LEVEL HEALTH EDUCATION AND AWARENESS
10
MHEALTH SOLUTIONS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables
137
10.2.1
PERSONALIZED AND CONVENIENT HEALTHCARE TO LEAD TO MARKET GROWTH
10.3
HEALTHCARE PROVIDERS
HEALTHCARE PROVIDERS INTEGRATING MHEALTH INTO
LEVERAGING MHEALTH TO IMPROVE OUTCOMES AND
10.5.1
SCALED MHEALTH FOR POPULATION-LEVEL HEALTHCARE TO DRIVE SEGMENT
11
MHEALTH SOLUTIONS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 175 Data Tables.
143
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2.1
MARKET DRIVEN BY RPM AND TELEHEALTH EXPANSION
11.2.3.1
MARKET DRIVEN BY DIGITAL ADOPTION AND INTEROPERABILITY
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2.1
DIGA REIMBURSEMENT AND DIGITAL HEALTH INTEGRATION TO DRIVE MARKET
11.3.3.1
MARKET DRIVEN BY NHS DIGITALIZATION AND AI ADOPTION
11.3.4.1
MARKET DRIVEN BY TELEMONITORING AND DIGITAL HEALTH INFRASTRUCTURE
11.3.5.1
MARKET DRIVEN BY PNRR, TELEMEDICINE, AND EHR EXPANSION
11.3.6.1
RISING FUNDING FOR DIGITAL HEALTH PLANS TO BOOST MARKET
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2.1
MARKET DRIVEN BY INTERNET HEALTHCARE AND AI-ENABLED CARE
11.4.3.1
RISING GERIATRIC POPULATION AND SUBSEQUENT RISE IN PREVENTIVE CARE TO DRIVE MARKET
11.4.4.1
GOVERNMENT INITIATIVES AND DIGITAL HEALTH TO DRIVE MARKET GROWTH
11.4.5.1
GROWING REMOTE MONITORING AND CONNECTED HEALTH RECORDS EXPANSION TO DRIVE MARKET
11.4.6.1
STRATEGIC PARTNERSHIPS AND AI INNOVATIONS ACCELERATING MHEALTH ADOPTION
11.4.7
REST OF ASIA PACIFIC
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2.1
MARKET DRIVEN BY SUS DIGITALIZATION AND CONNECTED CARE
11.5.3.1
MARKET DRIVEN BY AI-ENABLED CHRONIC CARE
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.7
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.7.1.1
MARKET DRIVEN BY VIRTUAL HOSPITALS AND AI-ENABLED CARE
11.7.2.1
EXPANDING CONNECTED HEALTHCARE ECOSYSTEM TO BOOST MARKET
11.7.3.1
CONNECTED RECORDS AND SMART HEALTH APPS TO BOOST MARKET
11.7.4.1
STRENGTHENING OF CONNECTED HEALTHCARE ECOSYSTEMS THROUGH DIGITAL HEALTH TRANSFORMATION TO PROPEL MARKET
11.7.5.1
MARKET DRIVEN BY MOBILE HEALTH AND DIGITAL PUBLIC HEALTHCARE
11.7.6
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover strategic insights and market positioning of key mHealth players through 2025.
259
12.2
KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET
12.3
REVENUE ANALYSIS, 2021–2025
12.4
MARKET SHARE ANALYSIS, 2025
12.4.1
RANKING OF KEY MARKET PLAYERS
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGIONAL FOOTPRINT
12.5.5.3
OFFERING FOOTPRINT
12.5.5.4
USE CASE FOOTPRINT
12.5.5.5
END USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.2
COMPANY FOOTPRINT (STARTUPS/SMES)
12.7
COMPANY VALUATION AND FINANCIAL METRICS
12.8
BRAND/PRODUCT COMPARISON
12.9
COMPETITIVE SCENARIO
12.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
12.9.3
OTHER DEVELOPMENTS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
280
13.1.1
KONINKLIJKE PHILIPS N.V.
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS & SERVICES OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.1.3.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
13.1.1.3.4
OTHER DEVELOPMENTS
13.1.1.4.2
STRATEGIC CHOICES
13.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
13.1.7
OMRON HEALTHCARE, INC.
13.1.9
BOSTON SCIENTIFIC CORPORATION
13.1.10
SIEMENS HEALTHCARE PRIVATE LIMITED
13.1.14
TELADOC HEALTH, INC.
13.1.20
AIRSTRIP TECHNOLOGIES, INC
13.2.1
NATURAL CYCLES NORDIC AB
14
RESEARCH METHODOLOGY
365
14.1.1.1
KEY DATA FROM SECONDARY SOURCES
14.1.2.1
KEY DATA FROM PRIMARY SOURCES
14.1.2.2
BREAKDOWN OF PRIMARY SOURCES
14.2
MARKET SIZE ESTIMATION
14.3
MARKET SIZE ESTIMATION
14.4
MARKET BREAKDOWN DATA TRIANGULATION
14.5
MARKET SHARE ESTIMATION
14.7
RESEARCH LIMITATIONS
14.7.1
METHODOLOGY-RELATED LIMITATIONS
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
USD EXCHANGE RATES
TABLE 2
MHEALTH SOLUTIONS MARKET: IMPACT ANALYSIS
TABLE 3
MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
MHEALTH SOLUTIONS MARKET: ROLE IN ECOSYSTEM
TABLE 5
INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025)
TABLE 6
INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY REGION (2025)
TABLE 7
MHEALTH SOLUTIONS MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 8
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 9
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR MHEALTH SOLUTIONS MARKET
TABLE 10
MHEALTH SOLUTIONS MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
NORTH AMERICA: REGULATORY ANALYSIS
TABLE 17
EUROPE: REGULATORY ANALYSIS
TABLE 18
ASIA PACIFIC: REGULATORY ANALYSIS
TABLE 19
MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
TABLE 20
LATIN AMERICA: REGULATORY ANALYSIS
TABLE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 23
UNMET NEEDS IN MHEALTH SOLUTIONS MARKET
TABLE 24
END USER EXPECTATIONS IN MHEALTH SOLUTIONS MARKET
TABLE 25
MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 26
MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 27
MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 28
MHEALTH SOLUTIONS MARKET FOR CHRONIC CARE MANAGEMENT APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 29
MHEALTH SOLUTIONS MARKET FOR MENTAL & BEHAVIORAL HEALTH APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 30
MHEALTH SOLUTIONS MARKET FOR GENERAL HEALTH & FITNESS APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 31
MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT & ADHERENCE APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 32
MHEALTH SOLUTIONS MARKET FOR WOMEN’S HEALTH APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 33
MHEALTH SOLUTIONS MARKET FOR DIAGNOSTIC & SYMPTOM CHECKER APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 34
MHEALTH SOLUTIONS MARKET FOR PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 35
MHEALTH SOLUTIONS MARKET FOR CLINICAL DECISION SUPPORT APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 36
MHEALTH SOLUTIONS MARKET FOR OTHER HEALTHCARE APPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 37
MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 38
MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
MHEALTH SOLUTIONS MARKET FOR VITAL SIGNS MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 40
MHEALTH SOLUTIONS MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 41
MHEALTH SOLUTIONS MARKET FOR MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 42
MHEALTH SOLUTIONS MARKET FOR FETAL & MATERNAL MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 43
MHEALTH SOLUTIONS MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 44
MHEALTH SOLUTIONS MARKET FOR SMART INHALERS & DRUG DELIVERY DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 45
MHEALTH SOLUTIONS MARKET FOR OTHER CONNECTED MEDICAL DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 46
MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47
MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
MHEALTH SOLUTIONS MARKET FOR REMOTE PATIENT MONITORING SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
MHEALTH SOLUTIONS MARKET FOR TELEHEALTH SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 50
MHEALTH SOLUTIONS MARKET FOR DIGITAL DISEASE MANAGEMENT SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 51
MHEALTH SOLUTIONS MARKET FOR OTHER SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 53
MHEALTH SOLUTIONS MARKET FOR PREVENTIVE CARE & WELLNESS, BY REGION, 2024–2031 (USD MILLION)
TABLE 54
MHEALTH SOLUTIONS MARKET FOR SCREENING & DIAGNOSIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 55
MHEALTH SOLUTIONS MARKET FOR TREATMENT & DISEASE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 56
MHEALTH SOLUTIONS MARKET FOR PATIENT MONITORING, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT & ADHERENCE, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
MHEALTH SOLUTIONS MARKET FOR CONSULTING & CARE COORDINATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 59
MHEALTH SOLUTIONS MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2024–2031 (USD MILLION)
TABLE 60
MHEALTH SOLUTIONS MARKET FOR OTHER USE CASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 61
MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 62
MHEALTH SOLUTIONS MARKET FOR PATIENTS/CONSUMERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 63
MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 65
MHEALTH SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 66
MHEALTH SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 67
NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68
NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 69
NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71
NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72
NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 73
NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 74
US: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 75
US: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 76
US: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 77
US: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 78
US: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 79
US: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 80
CANADA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 81
CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 82
CANADA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83
CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 84
CANADA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 85
CANADA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 86
EUROPE: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87
EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 88
EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89
EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90
EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91
EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 92
EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 93
GERMANY: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 94
GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95
GERMANY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96
GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
GERMANY: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 98
GERMANY: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 99
UK: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 100
UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101
UK: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102
UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
UK: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 104
UK: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 105
FRANCE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 106
FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107
FRANCE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108
FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
FRANCE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 110
FRANCE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 111
ITALY: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 112
ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113
ITALY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115
ITALY: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 116
ITALY: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 117
SPAIN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 118
SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 119
SPAIN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120
SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
SPAIN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 122
SPAIN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123
REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 124
REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125
REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126
REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127
REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 128
REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 131
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 132
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 135
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 136
CHINA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 137
CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138
CHINA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140
CHINA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 141
CHINA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 142
JAPAN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 143
JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144
JAPAN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
JAPAN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 147
JAPAN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 148
INDIA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 149
INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150
INDIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151
INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152
INDIA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 153
INDIA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 154
AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 155
AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156
AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157
AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158
AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 159
AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 160
SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 161
SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162
SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163
SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164
SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 165
SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 166
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 167
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 170
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 171
REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 172
LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173
LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 174
LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175
LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176
LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 178
LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 179
BRAZIL: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 180
BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181
BRAZIL: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182
BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183
BRAZIL: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 184
BRAZIL: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185
MEXICO: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 186
MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187
MEXICO: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188
MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189
MEXICO: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 190
MEXICO: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 191
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 192
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 196
REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 197
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 199
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 203
MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 204
GCC: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205
GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 206
GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207
GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208
GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209
GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 210
GCC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 211
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 212
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 216
SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 217
UAE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 218
UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219
UAE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220
UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
UAE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 222
UAE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 223
REST OF GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 224
REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
REST OF GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227
REST OF GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 228
REST OF GCC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 229
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 230
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 234
SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 235
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 236
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION)
TABLE 240
REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 241
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, JANUARY 2023–JUNE 2026
TABLE 242
MHEALTH SOLUTIONS MARKET SHARE ANALYSIS, 2025
TABLE 243
MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT, 2025
TABLE 244
MHEALTH SOLUTIONS MARKET: OFFERING FOOTPRINT, 2025
TABLE 245
MHEALTH SOLUTIONS MARKET: USE CASE FOOTPRINT, 2025
TABLE 246
MHEALTH SOLUTIONS MARKET: END USER FOOTPRINT, 2025
TABLE 247
MHEALTH SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS, 2025
TABLE 248
MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT (STARTUPS/SMES), 2025
TABLE 249
MHEALTH SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–AUGUST 2026
TABLE 250
MHEALTH SOLUTIONS MARKET: DEALS, JANUARY 2023–AUGUST 2026
TABLE 251
MHEALTH SOLUTIONS MARKET: EXPANSIONS, JANUARY 2023–AUGUST 2026
TABLE 252
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 253
KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
TABLE 254
KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 255
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026
TABLE 256
KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-JULY 2026, JANUARY 2023−AUGUST 2026
TABLE 257
KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
TABLE 258
MEDTRONIC: COMPANY OVERVIEW
TABLE 259
MEDTRONIC: PRODUCTS & SERVICES OFFERED
TABLE 260
MEDTRONIC: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 261
MEDTRONIC: DEALS, JANUARY 2023-AUGUST 2026
TABLE 262
ABBOTT: COMPANY OVERVIEW
TABLE 263
ABBOTT: PRODUCTS & SERVICES OFFERED
TABLE 264
ABBOTT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 265
ABBOTT: DEALS, JANUARY 2023-AUGUST 2026
TABLE 266
RESMED: COMPANY OVERVIEW
TABLE 267
RESMED: PRODUCTS & SERVICES OFFERED
TABLE 268
RESMED: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 269
RESMED, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 270
DEXCOM, INC.: COMPANY OVERVIEW
TABLE 271
DEXCOM, INC.: PRODUCTS & SERVICES OFFERED
TABLE 272
DEXCOM, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 273
DEXCOM, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 274
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 275
GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 276
GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 277
GE HEALTHCARE: DEALS, JANUARY 2023-AUGUST 2026
TABLE 278
GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
TABLE 279
OMRON HEALTHCARE, INC.: COMPANY OVERVIEW
TABLE 280
OMRON HEALTHCARE, INC.: PRODUCTS & SERVICES OFFERED
TABLE 281
OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 282
OMRON HEALTHCARE, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 283
ORACLE: COMPANY OVERVIEW
TABLE 284
ORACLE: PRODUCTS & SERVICES OFFERED
TABLE 285
ORACLE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 286
ORACLE: DEALS, JANUARY 2023–AUGUST 2026
TABLE 287
ORACLE: EXPANSIONS, JANUARY 2023-AUGUST 2026
TABLE 288
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 289
BOSTON SCIENTIFIC CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 290
BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 291
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–AUGUST 2026
TABLE 292
SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 293
SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCTS & SERVICES OFFERED
TABLE 294
SIEMENS HEALTHINEERS: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 295
SIEMENS HEALTHCARE PRIVATE LIMITED: EXPANSIONS, JANUARY 2023–AUGUST 2026
TABLE 296
OPTUM: COMPANY OVERVIEW
TABLE 297
OPTUM: PRODUCTS & SERVICES OFFERED
TABLE 298
OPTUM: DEALS, JANUARY 2023-AUGUST 2026
TABLE 299
ATHENAHEALTH: COMPANY OVERVIEW
TABLE 300
ATHENAHEALTH: PRODUCTS & SERVICES OFFERED
TABLE 301
ATHENAHEALTH: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 302
ATHENAHEALTH: DEALS, JANUARY 2023-AUGUST 2026
TABLE 303
EMPATICA INC.: COMPANY OVERVIEW
TABLE 304
EMPATICA INC.: PRODUCTS & SERVICES OFFERED
TABLE 305
EMPATICA INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 306
EMPATICA INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 307
EMPATICA INC.: EXPANSIONS, JANUARY 2023–AUGUST 2026
TABLE 308
TELADOC HEALTH, INC.: COMPANY OVERVIEW
TABLE 309
TELADOC HEALTH, INC.: PRODUCTS & SERVICES OFFERED
TABLE 310
TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 311
TELADOC HEALTH, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 312
WELLDOC, INC.: COMPANY OVERVIEW
TABLE 313
WELLDOC, INC.: PRODUCTS & SERVICES OFFERED
TABLE 314
WELLDOC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 315
WELLDOC, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 316
ALIVECOR, INC. COMPANY OVERVIEW
TABLE 317
ALIVECOR, INC. PRODUCTS & SERVICES OFFERED
TABLE 318
ALIVECOR, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 319
ALIVECOR, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 320
BIOFOURMIS: COMPANY OVERVIEW
TABLE 321
BIOFOURMIS: PRODUCTS & SERVICES OFFERED
TABLE 322
BIOFOURMIS: DEALS, JANUARY 2023–AUGUST 2026
TABLE 323
TUNSTALL GROUP: COMPANY OVERVIEW
TABLE 324
TUNSTALL GROUP: PRODUCTS & SERVICES OFFERED
TABLE 325
GARMIN LTD.: COMPANY OVERVIEW
TABLE 326
GARMIN LTD.: PRODUCTS & SERVICES OFFERED
TABLE 327
GARMIN LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 328
GARMIN LTD.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 329
AIRSTRIP TECHNOLOGIES, INC: COMPANY OVERVIEW
TABLE 330
AIRSTRIP TECHNOLOGIES, INC: PRODUCTS & SERVICES OFFERED
TABLE 331
AIRSTRIP TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026
TABLE 332
AIRSTRIP TECHNOLOGIES, INC.: DEALS, JANUARY 2023–AUGUST 2026
TABLE 333
RISK ASSESSMENT: MHEALTH SOLUTIONS MARKET
FIGURE 1
MHEALTH SOLUTIONS MARKET SEGMENTATION
FIGURE 3
GLOBAL MHEATLH SOLUTIONS MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MHEATLH SOLUTIONS MARKET, 2022–2026
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF MHEATLH SOLUTIONS MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN MHEATLH SOLUTIONS MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MHEATLH SOLUTIONS MARKET DURING FORECAST PERIOD
FIGURE 8
GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
FIGURE 9
MHEALTH APPS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11
MHEALTH SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12
MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 13
MHEALTH SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
FIGURE 14
MHEALTH SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
FIGURE 15
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17
JURISDICTION AND TOP APPLICANT ANALYSIS FOR MHEALTH SOLUTIONS MARKET
FIGURE 18
TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MHEALTH MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 19
MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS
FIGURE 20
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 23
NORTH AMERICA: MHEALTH SOLUTIONS MARKET SNAPSHOT
FIGURE 24
ASIA PACIFIC: MHEALTH SOLUTIONS MARKET SNAPSHOT
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, 2021–2025
FIGURE 26
MHEALTH SOLUTIONS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27
RANKING OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, 2025
FIGURE 28
MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29
MHEALTH SOLUTIONS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 30
MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31
EV/EBITDA OF KEY VENDORS, 2026
FIGURE 32
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026
FIGURE 33
MHEALTH SOLUTIONS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 34
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 35
MEDTRONIC: COMPANY SNAPSHOT (2025)
FIGURE 36
ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 37
RESMED: COMPANY SNAPSHOT (2026)
FIGURE 38
DEXCOM, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39
GE HEALTHCARE: COMPANY SNAPSHOT (2025)
FIGURE 40
OMRON HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 41
ORACLE: COMPANY SNAPSHOT (2026)
FIGURE 42
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 43
SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2025)
FIGURE 44
OPTUM: COMPANY SNAPSHOT (2025)
FIGURE 45
TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2025)
FIGURE 46
GARMIN LTD.: COMPANY SNAPSHOT (2025)
FIGURE 47
RESEARCH DESIGN
FIGURE 48
PRIMARY SOURCES
FIGURE 49
INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 50
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 51
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 52
BOTTOM-UP APPROACH
FIGURE 53
TOP-DOWN APPROACH
FIGURE 54
CAGR PROJECTIONS FROM ANALYSIS OF DROC IN MHEALTH SOLUTIONS INDUSTRY
FIGURE 55
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 56
DATA TRIANGULATION METHODOLOGY
Marie
Feb, 2020
Thanks for the extensive information. The healthcare-based mobile app market is multiplying. Experts are integrating new technologies into mobile applications to offer advanced levels of client interface and experience. As of 2019, most connected mHealth solutions market uses mobile apps to provide better client services..